Kala is a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary mucus-penetrating particle (MPP) technology, with an initial focus on the treatment of eye diseases. Kala has applied the MPP technology to a corticosteroid designed for ocular applications, resulting in two lead product candidates. The product candidates are INVELTYSTM(KPI-121 1%) for the treatment of inflammation and pain following ocular surgery, for which we have submitted a NDA, and KPI-121 0.25% for the temporary relief of the signs and symptoms of dry eye disease, which is currently in Phase 3 clinical development.

Financial Reporting Manager

Kala is an emerging pharmaceutical company on the verge of commercialization. We are seeking an Financial Reporting Manager with extensive SEC reporting experience.  This is an opportunity for the right individual to join Kala at a very exciting time.  Come join an experienced and highly motivated team!

Key Responsibilities for this role will include:

• Manage all aspects of our external SEC documents, including the 10K, 10Q, 8K and other ad hoc filings

• Partner with the VP and Controller to lead Sarbanes-Oxley compliance effort

• Coordinate the review of filings with external auditors, legal counsel, accounting staff and executive management

• Research accounting literature and apply technical US GAAP standards to complex business issues

• Lead implementation efforts and ongoing monitoring of significant new pronouncements, including ongoing communication and education of financial management on pronouncements

• With support from the accounting department, and coordinate the quarterly review and annual audit process with our external auditors

Our ideal candidate will have:    

• Bachelor/Masters degree in Accounting

•  5-7 years related experience

• Public accounting experience required with public company clients – straight from public or mix of public/industry

•  Big 4 experience strongly preferred

•  CPA required

•  Excellent Communication Skills (Written & Verbal)

•  Possess technical expertise related to GAAP and external reporting including SEC reporting, stock option accounting, revenue recognition, acquisitions, and Sarbanes-Oxley requirements

• Demonstrated recent experience in researching and preparing technical accounting memorandums for complex issues and new pronouncements

• Understanding of accounting processes, procedure and internal controls

• Ability to adapt quickly and learn new tasks independently

• Ability to manage competing priorities with deadlines

• Pharmaceutical or Life Science company experience
  
  About Us: Kala is a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary mucus-penetrating particle (MPP) technology, with an initial focus on the treatment of eye diseases. Kala has applied the MPP technology to a corticosteroid designed for ocular applications, resulting in two lead product candidates. The product candidates are INVELTYSTM(KPI-121 1%) for the treatment of inflammation and pain following ocular surgery, for which we have submitted a NDA, and KPI-121 0.25% for the temporary relief of the signs and symptoms of dry eye disease, which is currently in Phase 3 clinical development.

All your information will be kept confidential according to EEO guidelines.